FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine, and presents a pharmaceutical composition for injections for acute forms of parkinsonian syndrome characterised by the fact that an active substance is presented by a therapeutically effective amount of N-(2-adamantyl)-hexamethylenimine hydrochloride (hymantan), and additive substances are presented by water for injections or a physiological solution. The invention also concerns a method for preparing the pharmaceutical composition.
EFFECT: pharmaceutical composition possesses storage stability, releases the active substance easily that provides its high bioavailability and efficacy.
6 cl, 15 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ADAMANTYL DERIVATIVES OF BENZIMIDAZOLE, HAVING ANTIPARKINSONIAN ACTIVITY | 2023 |
|
RU2820315C1 |
| AGENT FOR TREATMENT AND PREVENTION OF PARKINSON'S DISEASE | 2006 |
|
RU2324492C1 |
| MEDICATION FOR TREATING PARKINSON'S DISEASE | 2009 |
|
RU2418577C1 |
| AGENT FOR MANAGING PAIN AND INFLAMMATION ACCOMPANYING NEURODEGENERATIVE DISORDERS | 2012 |
|
RU2559777C2 |
| MEDICATION FOR TREATING CEREBRAL CIRCULATION DISORDERS AND BRAIN TRAUMAS | 2012 |
|
RU2554502C9 |
| PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING CHRONIC FATIGUE SYNDROME DUE TO ITS APPLICATION | 2003 |
|
RU2267319C2 |
| 2-((1H-1,2,4-TRIAZO-3-YL)THIO)-3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-EN-1-OL AS AN ANTIPARKINSONIAN AGENT | 2022 |
|
RU2796729C1 |
| 2-METHOXY-4[(3aR,7aS)-3,3,6-TRIMETHYL-1,3,3a,4,5,7a-HEXAHYDRO-2-BENZOFURAN-1-YL]PHENOL - NOVEL AGENT FOR TREATING PARKINSON'S DISEASE | 2010 |
|
RU2436782C1 |
| PHARMACEUTICAL COMPOSITION IN GEL MEDICINAL FORM FOR LOCAL USE ON THE BASIS OF N-(2-ADAMANTIL)-HEXAMETHYLENEMINE HYDROCHLORIDE | 2017 |
|
RU2663452C1 |
| BIOLOGICALLY ACTIVE HETEROGLYCOSIDE FOR CORRECTION OF PATHOLOGICAL STATES OF CENTRAL NERVOUS SYSTEM | 2006 |
|
RU2335289C2 |
